Targeted Muscle Reinnervation for Management and Prevention of Symptomatic Neuroma

Area of Science:

• Peripheral nerve surgery
• Neuropathic pain management
• Regenerative medicine

Background:

• Symptomatic neuromas cause chronic neuropathic pain, especially in amputees.
• Traditional treatments like neurectomy have limited success and high recurrence rates.
• Current methods fail to address the root cause of aberrant axonal regeneration.

Purpose of the Study:

• To evaluate the efficacy of targeted muscle reinnervation (TMR) in preventing and treating neuropathic pain.
• To explore TMR's role in improving patient outcomes beyond pain reduction.
• To highlight TMR's transition from prosthetic applications to comprehensive pain management.

Main Methods:

• Targeted Muscle Reinnervation (TMR) as an active nerve reconstruction strategy.
• Utilizing TMR to provide organized axonal regeneration targets.
• Investigating TMR's potential to interrupt central pain sensitization mechanisms.

Main Results:

• Level I evidence shows TMR is superior to traditional treatments for neuropathic pain.
• TMR achieved sustained pain relief in 82% of patients.
• Significant improvements in quality of life, sleep, and psychosocial well-being were observed.

Conclusions:

• TMR is a transformative approach for managing neuropathic pain after peripheral nerve injury.
• Its applications are expanding beyond amputees to diverse anatomical locations.
• TMR represents a key advancement in personalized nerve surgery for chronic pain.